Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SAS AWARDED CONTRACT WITH EQUINOR

SAS has signed a contract extension for three years with Equinor for both domestic and international travel.The contract with Equinor represents a significant contribution to SAS’ passenger volume in Norway. SAS was chosen on the basis of an extensive network, attractive timetable, commercial terms and one of Europe’s most modern fleets. “We are delighted that Equinor once again have chosen SAS as their preferred carrier for business travel, demonstrating a continued confidence in us for the next three years. SAS' strategic priorities to retain and further strengthen our position in

Correction: Inside Information: Preliminary information on adjusted operating profit for 2023

Wetteri Plc Inside information 9 February 2024 12.00 EETOn February 1st, 2024, Wetteri Oyj gave preliminary information on the unaudited adjusted operating profit for 2023 in its insider information release. The stock exchange release stated that according to the group's unaudited preliminary information, the adjusted operating profit for 2023 is approximately EUR 11.7 million. The company corrects preliminary information: According to the group's unaudited preliminary information, the adjusted operating profit for 2023 is over EUR 11.7 million. Additional information: Aarne Simula,

Panoro Energy – Timing Change for Equatorial Guinea Drilling Campaign

Oslo, 9 February 2024 – Panoro Energy ASA (“Panoro” or the “Company”) provides an update on the drilling campaign offshore Equatorial Guinea that commenced on Block G in January.   Upon recommendation of the Operator, Trident Energy, the joint venture has decided to terminate the current rig contract. The joint venture is of the view that the rig is not operationally in a condition to safely drill the wells.  The Operator is, on behalf of the joint venture, evaluating alternative options that will allow for the recommencement and safe completion of the intended drilling campaign (

QLIFE HOLDING AB, Interim Report Q4, January to December 2023

Looking ahead with new partnersFinancial summary – fourth quarter 2023 · Revenue in the period amounted to kSEK 30 (1,097). Revenue includes sales of Egoo.Health devices and capsules for the device. Revenue in Q4 is solely from test orders of CRP capsules and Egoo systems. · EBITDA for the period amounted to kSEK –9,466 (-16,843), and net loss kSEK –111,547 (-25,413). · The total cash flow in the fourth quarter amounted to kSEK -6,095 (3,103). · Earnings per share before/after dilution for the quarter amounted to SEK -0,019 (-1.17), calculated on weighted average number of

Stena Recycling awarded for wind turbine blade circularity solution

Stena Recycling, in cooperation with Olin Corporation, Vestas Wind Systems, Aarhus University, and Danish Technological Institute, has been recognized with 2024 Global Innovation Award by JEC Composites in the Renewable Energies category. The group is rewarded for having developed a solution that enables the recycling of materials from wind turbine blades on a lab scale. Wind turbine blades have previously been challenging to recycle due to the chemical properties of epoxy resin, a resilient substance that was believed to be impossible to break down into re-usable components.

Invitation to presentation of year-end report for 2023

On Friday, February 15, at 1:00 pm, the year-end report for Cabonline Group Holding AB (publ) (the "Company") for 2023 will be published. In addition, there will be an opportunity for analysts and bond investors for a presentation meeting on Friday, February 16 2024, at 2:00 pm.Cabonline's CEO Dag Kibsgaard-Petersen and CFO Fredrik Lundqvist are available for a digital meeting with analysts and bond investors on Friday, February 16, at 2:pm. To book a meeting, please contact Aase Livbom, Pareto Securities, events.se@paretosec.com or +46 8 402 51 04. For further information, please

Teesside University puts academic expertise in the spotlight

A spotlight is being put on television crime dramas, the murky world of the illegal wildlife trade, forensic investigations into unexplained deaths, and the darker side of tourism, through a new series to be launched by Teesside University.Spotlight is a series of talks aimed to inspire, intrigue and entertain audiences across the Tees Valley, sharing the University’s academic expertise in everyday subjects with the local communities it serves. Thought-provoking insight will be offered on a range of subjects at venues across Teesside. Admission will be free. Doors open at 6pm. Locations

Metsä Group's tissue and greaseproof paper business achieves the second highest A- score in CDP's climate change assessment

PRESS RELEASE 9.2.2024 AT 10.48 Metsä Group's tissue and greaseproof paper business has achieved CDP’s second highest 'A-' score, which is a  Leadership level recognition of its actions in combating climate change. CDP assesses annually companies on their environmental transparency and performance in climate change work. This is the second time that Metsä Group’s tissue and greaseproof paper business completed the Climate Change Survey. The achieved result is higher than the European regional average on level 'B'  and higher than wood and paper material sector's overall average level '

Irish study shows that Monivent Neo Training improves neonatal resuscitation training

The International Liaison Committee on Resuscitation (ILCOR) has recommended improvements in training for neonatal resuscitation, highlighting the potential role of respiratory function monitors (RFMs). A recent study concluded that standardized training with a simple interface RFM (Neo Training) led to a significant reduction in mask leakage and improvement in all other ventilation parameters. The study has been led by Dr Caitriona M Ni Chathasaigh, The National Maternity Hospital, Dublin and involves a large group of healthcare professionals in maternity and neonatal services.The study "

Tokmanni Group’s Dollarstore continues to expand its store network both in Sweden and Denmark – Store opening ceremonies will be held in Uddevalla and Frederikshavn

Tokmanni Group Corporation     Press release     9 February 2024 at 10:30 a.m. Dollarstore, which has been part of Tokmanni Group since August 2023, currently has 130 Dollarstore stores in Sweden and four Bigdollar stores in Denmark. The latest stores were opened in Denmark: in Hjørring in September and in Holbæk in November last yer. The Swedish discount retailer Dollarstore , which Finnish variety discount retailer Tokmanni Group  acquired in August 2023, will open a new store both in Uddevalla in Sweden and in Frederikshavn

Elicera Therapeutics receives approval to initiate clinical Phase I/II-study CARMA with CAR T-cell therapy ELC-301 in B-Cell lymphoma

Gothenburg, February 9, 2024 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation cancer treatments based on its proprietary commercial technology platform iTANK, today announced that the company has received approval from the Swedish Medical Products Agency to start the clinical phase I/II study CARMA in patients with B-cell lymphoma that no longer respond to standard treatment or have relapsed.CARMA is a single-arm, unblinded, multicenter study that aims to evaluate the safety profile and treatment effect after one dose of ELC-301. It

BioStock: 2023 springboard for Spago’s radionuclide cancer therapy

In 2023, Swedish biotech Spago Nanomedical kicked off its journey in the clinic with radionuclide cancer therapy Tumorad. Ending the year with the first patient dosed in the phase I trial and a SEK 30.6 million capital raise, Spago has strong momentum going into 2024. BioStock spoke with Spago’s CEO Mats Hansen to hear about the progress made in 2023 and what he is most looking forward to this year.Read the interview with Mats Hansen at biostock.se: 2023 springboard for Spago’s radionuclide cancer therapy - BioStock 

Prostatype Genomics receives CAP laboratory accreditation, achieves another milestone towards entering the US market

Prostatype Genomics AB ("Prostatype Genomics" or "the Company") announces that its wholly-owned US subsidiary Prostatype Genomics, Inc. has been accredited by the CAP (College of American Pathologists) Laboratory Accreditation Program. The Company has thus achieved three major regulatory milestones in February 2024 towards entering the US market: a signed CLIA laboratory agreement with its lab partner ResearchDx, acquisition of a CLIA Certificate, and now CAP laboratory accreditation. The final regulatory step needed before being able to enter the US prostate cancer market is a formal

Minesto reaches historic milestone – first electricity to grid with tidal powerplant Dragon 12 (1.2 MW)

Minesto, leading ocean energy developer, today announces that a key milestone has been reached: The utility-scale tidal powerplant Dragon 12 - rated at 1.2 MW - has been successfully commissioned and, in the early morning of February 9, delivered its first electricity to the national grid in the Faroe Islands.The Dragon 12 is Minesto’s first tidal energy kite in megawatt-scale. It has now been successfully commissioned and has generated electricity at satisfactory levels in its first phase of operation. The 12-meter wide and 28-ton heavy subsea kite, anchored with a tether to the seabed, is

New roof for 16 apartment buildings in Ukraine with roofing products donated by SSAB & Ruukki

Humanitarian reconstruction work in Ukraine, coordinated by the Swedish charity organization OperationAid, has progressed to repair houses damaged by Russian aggression. In January 2024, sixteen apartment buildings in the Mykolaiv region were renovated with roofing materials donated by SSAB and Ruukki. The war in Ukraine continues with devastating effects. To help people in need, we donated approximately 2,500 square meters of roofing materials for the reconstruction in December 2023. The products were manufactured from SSAB's steel at the Ruukki plant near Kiev. “Sixteen multi-

Invitation to web presentation of Formpipe’s Q4 report 2023.

Formpipe will publish its interim report for the forth quarter 2023 on Friday 16 February 2024 at 08:15 (CET).The same day at 11:00 (CET), Formpipe’s President and CEO Magnus Svenningson will host a web presentation in English which is webcasted live on: http://www.formpipe.com/en/q42023, where it also will be available on demand shortly afterwards. Following the presentation, Magnus Svenningson, and Joakim Alfredson CFO, will be available to answer questions. The report and presentation will be available at: www.formpipe.com/en/investors/reports-and-presentations Welcome!

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 9, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On February 8, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |3,497 |4.0139

Brain+ partners with Quiddity Health, the #1 UK digital healthcare market specialist, to prepare UK market entry for CST-Therapist Companion

·Quiddity Health has a strong track-record of helping innovative digital therapeutic companies successfully enter the UK healthcare market and reach commercial scale    ·Brain+ plans to have a UK version 2.0 of CST-Therapist Companion, its new digital solution to support effective dementia therapy, ready for UK market release in Q3 2024  ·Initially, Quiddity Health will work with Brain+ to develop a targeted go-to-market plan for CST-Therapist Companion in the UK and build relevant pre-sale customer engagements   ·Post market release, Quiddity Health will act as Brain+’

Year-end Report 1 January – 31 December 2023

· Continued stable growth despite restructuring of commercial organization, and satisfactory start in the US with significant opportunities ahead · Restructuring program completed with planned cost reduction expected 2024 · 510(k)-process ongoing with US FDA for big toe implant“Despite significantly restructuring our sales force, we ended the year with another record quarter. On average, we have grown our gross order intake by more than 50% during the last five quarters. During 2023, the gross order intake reached SEK 11.1m (+56%). The usage of our technology increased globally and

Elicera Therapeutics receives approval to initiate clinical Phase I/II-study CARMA with CAR T-cell therapy ELC-301 in B-Cell lymphoma

Gothenburg, February 9, 2024 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation cancer treatments based on its proprietary commercial technology platform iTANK, today announced that the company has received approval from the Swedish Medical Products Agency to start the clinical phase I/II study CARMA in patients with B-cell lymphoma that no longer respond to standard treatment or have relapsed.CARMA is a single-arm, unblinded, multicenter study that aims to evaluate the safety profile and treatment effect after one dose of ELC-301. It

The exercise period for warrants of series TO3 begins today

NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ACTION OTHER THAN THAT REQUIRED BY SWEDISH LAW. Today, on February 9, 2024, the subscription period begins for the warrants of series TO3 in Pharmacolog i Uppsala AB (“Pharmacolog” or the “Company”). The subscription period runs until February 23, 2024.Summarized

ClimateView and AFRY enter partnership for data-driven green transitions in cities

To support cities, municipalities and regions in accelerating their journey towards carbon neutrality, Swedish technology company ClimateView and global engineering and design company AFRY have entered a partnership with a joint offering, combining leading expertise from two disciplines.Cities are critical players in combating climate change, as they are hubs for innovation, economic activity and account for more than 70 percent of global CO2 emissions. Their dense populations and infrastructure offer a concentrated opportunity for both impactful policy changes and scalable sustainability

Fastighets AB Balder’s (publ) year-end report January-December 2023

· Profit from property management attributable to the parent company’s shareholders amounted to SEK 6,135m (6,139), corresponding to a decrease per share by 3% to SEK 5.32 (5.48).  · Long term net asset value amounted to SEK 85.06 per share (92.10).  · Rental income amounted to SEK 11,944m (10,521).  · Profit after tax attributable to the parent company’s shareholders amounted to SEK -6,746m (10,175) corresponding to SEK -5.85 per share (9.09). Profit from property management for the year amounted to SEK 6,549m (6,659). Profit from property management attributable to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top